1,355 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Intuitive Surgical recalled 47 da Vinci 5 Surgeon Console Viewer Displays on December 30, 2025. The devices may lose display functionality, risking surgical injury. Healthcare providers should stop using the consoles immediately and follow recall instructions.
Siemens Medical Solutions USA recalled five LUMINOS Q.namix T X-ray systems on December 29, 2025. The recall affects devices that can process images from previous patients due to a software issue. Healthcare providers must stop using these devices immediately.
Siemens Medical Solutions USA recalled 40 units of its LUMINOS Q.namix R X-ray system on December 29, 2025. The recall addresses a defect that may result in images being incorrectly processed, potentially showing images from previous patients. Healthcare providers should stop using the device immediately and follow recall instructions.
Cerapedics recalled 237 units of PearMatrix P-15 Peptide Enhanced Bone Graft on December 29, 2025. The recall affects products distributed nationwide after a review revealed incorrect expiration dates. Patients and healthcare providers should stop using the product immediately.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Gold Star Distribution recalled Claritin, 20 Count, on December 26, 2025, due to insanitary conditions resulting from rodent exposure. The recall affects an unknown quantity distributed nationwide. Consumers should stop using the product immediately.
Gold Star Distribution recalled PEPCID COMPLETE - 25CT on December 26, 2025 due to insanitary conditions, including rodent exposure. The recall affects all lots distributed by Gold Star and poses a high health risk. Consumers should stop using this product immediately and seek guidance from healthcare providers.
Gold Star Distribution recalled DayQuil Cold & Flu, 32CT/2PK on December 26, 2025, due to insanitary conditions including rodent exposure. Consumers should stop using the product immediately. The recall affects an unknown quantity of all lots distributed within expiry.
Gold Star Distribution recalled Alka Seltzer on December 26, 2025, due to insanitary conditions at their distribution center. The recall affects Original and Plus Cold & Flu formulations sold in various packaging. Consumers should stop using the product immediately due to potential health risks.
Gold Star Distribution recalled Benadryl on December 26, 2025, due to insanitary conditions linked to rodent activity. The recall impacts all lots within expiry distributed by the company. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.